Core Insights - True value in investments is derived from growth rather than short-term gains, emphasizing a long-term perspective on evaluation [1] - Great businesses provide significant societal value and exhibit durability, deserving growth proportional to their superiority [1] - Key characteristics sought in businesses include selection, convenience, value, and durability, with a preference for non-cyclical operations [1] Business Characteristics - Businesses that consistently outperform competitors through superior products and services are favored [1] - The ability to create multiple revenue streams and maintain anti-fragile structures is essential for long-term success [1] - Uniqueness is identified as the primary driver of value, with low maintenance costs allowing for high reinvestment potential [1] Management and Strategy - Trust and network effects are critical indicators of a business's durability [1] - Management quality is paramount, with a preference for executives who have aligned interests and a strong focus on the business [1] - Successful companies, like Amazon, demonstrate that a customer-centric approach can yield extraordinary returns [1] Investment Timing and Strategy - The optimal time for investment is when negative news is fully priced in, revealing true value [1] - Companies that can withstand adversity and show resilience are more attractive for investment [1] - A strategy of buying back shares is recommended for businesses with durable models, particularly during downturns [1]

Core Insights - FitLife Brands, Inc. announced the resignation of Todd Ordal from its Board of Directors, effective April 25, 2025, as part of its commitment to refresh board composition in line with good corporate governance practices [1][4] - Shannon Pappas has been appointed as an independent director to fill the vacancy left by Mr. Ordal and will serve on the Audit, Compensation, and Nominating/Corporate Governance Committees [2] - Ms. Pappas brings over 25 years of experience in beauty, skincare, health, fitness, and consumer goods, with expertise in strategic growth, digital commerce, financial management, and market expansion [3] Company Developments - The Board of Directors expressed gratitude for Todd Ordal's contributions over his ten years of service, highlighting his role in strategy, marketing, and organizational effectiveness [4] - The company anticipates further changes to the Board composition in the coming years as part of its governance practices [5] - FitLife Brands is a developer and marketer of nutritional supplements and wellness products, offering over 250 products primarily online and through various retail locations [6]

OMAHA, NE, April 22, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (Nasdaq: FTLF), today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 9:30 AM (Local Time - PST). Dayton Judd, the Company’s Chairman & CEO, and Ryan Hansen, the Company’s Executive Vice President, will be hosting the presentation and answering questions at the conclusion. Investors can access the live presentation u ...

Company Overview - FitLife Brands Inc. (FTLF) shares increased by 13.1% to close at $13.34, following a period of 12.7% loss over the past four weeks, indicating a significant rebound in investor sentiment [1] - The stock's price surge was supported by high trading volume, with more shares exchanged than usual [1] Insider Activity - Investor optimism was bolstered by director Todd Ordal purchasing 300 shares at $12.07 per share on April 15, and another director, Matthew Lingenbrink, acquiring 3,000 shares for approximately $36,510 [2] Earnings Expectations - FitLife Brands is projected to report quarterly earnings of $0.24 per share, reflecting a year-over-year increase of 9.1%, while revenues are expected to be $15.84 million, a decrease of 4.3% from the previous year [3] - The consensus EPS estimate has been revised 100% lower over the last 30 days, which typically does not correlate with price appreciation [4] Industry Context - FitLife Brands operates within the Zacks Medical - Products industry, where another company, LeMaitre Vascular (LMAT), reported a 1.9% increase in stock price, closing at $86.28, with a slight decline of 0.2% over the past month [4] - LeMaitre's consensus EPS estimate remains unchanged at $0.50, representing a year-over-year increase of 13.6%, and it holds a Zacks Rank of 2 (Buy) [5]

FitLife Brands, Inc. (NASDAQ:FTLF) Q4 2024 Results Conference Call March 27, 2025 4:30 PM ET Company Participants Dayton Judd - Chief Executive Officer Jakob York - Chief Financial Officer Conference Call Participants Ryan Meyers - Lake Street Capital Markets Samir Patel - Askeladden Capital James Bogan - Legend Capital Igor Novgorodtsev - Lares Capital Sean McGowan - ROTH Capital Partners Operator Good day, and welcome to the FitLife Brands' Fourth Quarter 2024 Financial Results. At this time, all particip ...

Financial Data and Key Metrics Changes - For the full year 2024, total revenue increased by 22% year over year to $64.5 million, with online sales growing by 29% and representing 67% of total revenue [3] - Gross profit increased by 31%, and gross margin expanded from 40.7% to 43.6% [3] - Net income rose by 70% to $9 million, with basic EPS increasing by 66% to $0.98 and fully diluted EPS increasing by 69% to $0.91 [3] - Adjusted EBITDA for the full year increased by 39% to $14.1 million [4] - For Q4 2024, total revenue increased by 13% to $15 million, with online revenue increasing by 12% to $10.1 million [4] Business Line Data and Key Metrics Changes - Legacy Fitlife revenue for Q4 2024 was $5.3 million, with a 20% decline in wholesale revenue and a 1% decline in online revenue, totaling a 13% decline [5][6] - MRC revenue for Q4 2024 was $6.9 million, down slightly by 0.4% year over year, but gross margin increased from 40.4% to 48.7% [9][10] - MusclePharm revenue for Q4 2024 was the strongest since acquisition, with total revenue increasing by 14% sequentially, driven by a 37% increase in wholesale revenue [13][14] Market Data and Key Metrics Changes - The company expects MRC online revenue to decline by 10-13% in Q1 2025 due to tough year-over-year comparisons [11] - The first quarter of 2025 is anticipated to see a consolidated revenue decline of 4% to 6% compared to Q1 2024, primarily due to MRC's performance [18] Company Strategy and Development Direction - The company is focused on increasing promotional spending to drive sales growth, particularly for MusclePharm, while managing gross margins [14][45] - The company is actively evaluating M&A opportunities, prioritizing larger transactions while maintaining a strong balance sheet [19][55] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for Q1 2025, expecting strong performance for legacy Fitlife despite challenges in Q4 2024 [8] - The company is taking steps to mitigate tariff impacts by exploring alternative sourcing options, particularly from India [24][28] - Management noted that while there is uncertainty in the market, they are seeing an uptick in deal flow, particularly from over-leveraged companies [60] Other Important Information - The company completed a two-for-one forward stock split on February 7, 2025, with all per-share amounts adjusted retroactively [3] - The balance sheet remains strong, with net debt at $8.6 million, equivalent to 0.6 times the company's LTM adjusted EBITDA [4][19] Q&A Session Summary Question: What is the potential tariff impact and sourcing from China? - The company does not source products from China but is assessing where manufacturers obtain ingredients, with India emerging as a promising alternative [22][24] Question: What are the dynamics affecting MRC's performance? - The decline in MRC revenue is attributed to tough year-over-year comparisons and changes in customer purchasing behavior [29][30] Question: What are the expectations for MusclePharm's ramp-up throughout the year? - The company is optimistic about MusclePharm's growth potential, particularly with new product launches and rebranding efforts [39][42] Question: Can gross margins be increased? - Gross margins could be increased by stopping promotional spending, but the focus is on growth rather than immediate margin improvement [71][73] Question: What is the company's approach to promotional expenses? - Promotional expenses are used to incentivize retailers to promote products, and the company can adjust these as needed based on performance [45][51]

Financial Data and Key Metrics Changes - For the full year 2024, total revenue increased by 22% year over year to $64.5 million, with online sales growing by 29% and representing 67% of total revenue [3][4] - Gross profit increased by 31%, and gross margin expanded from 40.7% to 43.6% [3] - Net income rose by 70% to $9 million, with basic EPS increasing by 66% to $0.98 and fully diluted EPS increasing by 69% to $0.91 [3] - Adjusted EBITDA for the full year increased by 39% to $14.1 million [4] - For Q4 2024, total revenue increased by 13% to $15 million, with online revenue increasing by 12% to $10.1 million [4] Business Line Data and Key Metrics Changes - Legacy Fitlife revenue for Q4 2024 was $5.3 million, with a 20% decline in wholesale revenue and a 1% decline in online revenue, totaling a 13% decline [5][6] - MRC revenue for Q4 2024 was $6.9 million, down slightly by 0.4% year over year, but gross margin increased from 40.4% to 48.7% [9][10] - MusclePharm revenue for Q4 2024 was the strongest since acquisition, with total revenue increasing by 14% sequentially, driven by a 37% increase in wholesale revenue [13][14] Market Data and Key Metrics Changes - The company expects MRC online revenue to decline by 10-13% in Q1 2025 due to tough year-over-year comparisons [11] - The first quarter of 2025 is anticipated to see a consolidated revenue decline of 4% to 6% compared to the first quarter of 2024 [18] Company Strategy and Development Direction - The company is focused on transitioning to direct fulfillment for GNC franchisees after resolving a commercial dispute [8] - There is an ongoing effort to optimize the skincare brands acquired in the MRC transaction, which had unprofitable revenue [10] - The company is actively evaluating M&A opportunities, prioritizing larger transactions while maintaining a strong balance sheet [19][20] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for Q1 2025, expecting strong performance for legacy Fitlife despite challenges in wholesale [9] - The company is taking proactive steps to mitigate potential tariff impacts by sourcing ingredients from alternative suppliers [24][28] - Management noted that while there is uncertainty in the market, they are seeing an uptick in deal flow, particularly from over-leveraged companies [60] Other Important Information - The company completed a two-for-one forward stock split on February 7, 2025, with all per-share amounts adjusted retroactively [3] - The balance sheet remains strong, with net debt at $8.6 million, equivalent to 0.6 times the company's LTM adjusted EBITDA [4][19] Q&A Session Summary Question: What is the potential tariff impact and sourcing from China? - The company does not source products from China but is assessing where manufacturers obtain ingredients, with India emerging as a promising alternative [22][24] Question: What are the dynamics affecting MRC business? - The decline in MRC revenue is attributed to tough year-over-year comparisons and changes in customer purchasing behavior [29][34] Question: What are the expectations for MusclePharm's ramp-up? - The company is optimistic about MusclePharm's growth potential but cannot provide specific numbers at this time [39][42] Question: How does promotional spending affect gross margins? - Promotional spending is typical in the industry and is accounted for as a reduction in gross revenue, impacting reported gross margins [45][49] Question: What is the company's approach to M&A targets? - The company is looking for larger M&A opportunities and can leverage its strong balance sheet to finance acquisitions [56][60] Question: What were MusclePharm's peak sales and future potential? - MusclePharm's peak revenue was over $175 million, and the company aims to recover a significant portion of that in the future [63][66]

Acquisitions - FitLife Brands acquired MusclePharm on October 10, 2023, enhancing its portfolio of nutritional supplements and wellness products[21]. - The Company completed the acquisition of Mimi's Rock Corp. on February 28, 2023, and the acquisition of substantially all assets of MusclePharm on October 10, 2023[97]. - The Company acquired Mimi's Rock Corp. on February 28, 2023, and MusclePharm on October 10, 2023, expanding its product offerings significantly[127]. Product Development and Launches - The company launched a total of 23 new products in 2024, including 19 completely new products and 4 reformulations, while 18 new products were introduced in 2023[24]. - FitLife Brands' marketing strategy includes social media campaigns and online advertising to build brand awareness and drive sales[30]. - The Company continues to reformulate and introduce new products while expanding its e-commerce capabilities to drive incremental sales[162]. - MusclePharm launched the new Pro Series in a pilot program in mid-March 2025, targeting high-volume Vitamin Shoppe stores[185]. Sales and Revenue - Revenue for the year ended December 31, 2024 increased 22% to $64,469 million compared to $52,700 million for the year ended December 31, 2023[158]. - Online revenue accounted for approximately 67% of total revenue for the year ended December 31, 2024, up from roughly 63% in 2023[150]. - MRC revenue for the year ended December 31, 2024 was $29,036 million, with MusclePharm generating $10,046 million in revenue[160]. - FitLife Consolidated's total revenue for Q4 2024 was $15,013 million, a 13% increase compared to Q4 2023, with gross profit rising by 16%[187]. Financial Performance - Gross profit for the year ended December 31, 2024 increased 31% to $28,080 million from $21,432 million in the previous year[164]. - Net income for the year ended December 31, 2024 was $8,984 million, a 70% increase compared to $5,296 million for the year ended December 31, 2023[169]. - The company's adjusted EBITDA for 2024 was $14,125 million, up from $10,179 million in 2023[192]. - As of December 31, 2024, the Company had positive working capital of $6,832 million, an increase from $4,356 million at the end of 2023[193]. Market and Competition - The company operates in a highly competitive nutrition industry, differentiating its products based on quality and functional ingredients[33]. - The company faces significant competition in the nutritional supplements market, with competitors often offering a wider range of products and more competitive pricing[50]. - The nutritional supplement industry has been growing, but a slower growth rate could lead to reduced revenue and challenges in sustaining consistent growth[70]. Regulatory Compliance and Risks - The company is committed to regulatory compliance across various authorities, including the FDA and FTC, to ensure product safety and accurate marketing[34][40]. - Legal and regulatory risks could lead to significant compliance costs and negatively impact the marketing of the company's products[90]. - Certain products are subject to heightened regulatory scrutiny, resulting in increased operational costs and potential delays in product sales[92]. Debt and Financial Obligations - As of December 31, 2024, the company had approximately $13.0 million in total debt, with potential for additional indebtedness to fund future acquisitions[80]. - The company’s ability to meet debt service obligations will depend on future performance, which is influenced by various external factors[81]. - Rising interest rates may increase the cost of servicing debt, negatively affecting profitability and cash flows[87]. - The Company amended the Line of Credit Agreement to increase the Line of Credit to $3.5 million and extended the maturity date to December 23, 2023[195]. Operational Efficiency - The company relies on third-party manufacturers for product supply, which could lead to product recalls and reduced revenue if errors occur[91]. - The company is currently dependent on a limited number of independent suppliers and manufacturers, which may affect timely product deliveries and revenue[66]. - The company has never paid cash dividends on its Common Stock and does not anticipate paying any cash dividends in the foreseeable future[103]. Employee and Workforce - As of December 31, 2024, the company had 39 full-time employees, an increase from 37 in 2023[45]. Stock Performance - The closing price of the company's Common Stock ranged from a high of $17.50 to a low of $9.60 during the year ending December 31, 2024[100]. - The high and low closing prices for Common Stock in Q2 2024 were $17.50 and $12.25, respectively, indicating a price increase of approximately 103% from Q1 2024[117]. - The Share Repurchase Program allows the Company to repurchase up to $5,000,000 of Common Stock over the subsequent 24 months, with no shares repurchased during the year ended December 31, 2024[120][119].

FitLife Brands Inc. (FTLF) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on March 27, 2025, might help the stock move higher if these key numbers are bett ...

Financial Results - FitLife Brands, Inc. announced preliminary financial results for the fiscal year ended December 31, 2024[5]. - The financial results include key metrics that will be elaborated in the attached press release[5]. Corporate Communications - The company issued a press release on March 13, 2025, detailing its financial performance[5]. - A new corporate presentation was introduced for business purposes on the same date[6]. - The press release and corporate presentation are attached as Exhibits 99.1 and 99.2, respectively[8]. Company Information - The company is registered under the trading symbol FTLF on the Nasdaq Capital Market[3]. - FitLife Brands, Inc. has not elected to use the extended transition period for new financial accounting standards[4]. - The company is not classified as an emerging growth company[3]. - The company’s headquarters is located in Omaha, Nebraska[2]. - The report was signed by CEO Dayton Judd on March 13, 2025[12].